First Activated Site Becomes Highest Enroller in Depression Trial
The sponsor was facing a six-month first-patient-in delay, with no sites activated nationwide and an urgent need to enroll 200 patients across 20 sites. With the study timeline at critical risk, the sponsor needed a site that could move quickly from activation to screening while still protecting data quality, eligibility standards, and participant readiness in a complex psychiatric trial.
Read More












